Flolan 1.5 mg

FLOLAN 1.5 MG is a powder for solution containing epoprostenol sodium, used for intravenous administration. It is commonly associated with managing certain cardiovascular conditions. This medication is manufactured by GlaxoSmithKline Inc. in Canada.

FLOLAN 1.5 MG, containing epoprostenol sodium, is typically used for intravenous administration to manage specific cardiovascular conditions. Epoprostenol is a prostaglandin analog that helps in improving blood flow and reducing pressure in the pulmonary arteries. It is often prescribed for conditions where maintaining adequate circulation is crucial.

Common effects of FLOLAN 1.5 MG may include flushing, headache, and dizziness. Some users might experience nausea or vomiting. These effects can vary depending on individual tolerance and the specific condition being treated. Always consult a healthcare provider for personalized advice.

FLOLAN 1.5 MG should be handled with care, ensuring proper storage and preparation. It is important to follow the instructions provided by a healthcare professional for administration. Patients should be monitored closely during treatment to manage any potential adverse reactions.

FLOLAN 1.5 MG may interact with other medications, particularly those that affect blood pressure or heart rate. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.